SYRACUSE UNIVERSITY
🇦🇪United Arab Emirates
- Country
- 🇦🇪United Arab Emirates
- Ownership
- Private
- Established
- 1870-03-24
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.syracuse.edu
Clinical Trials
32
Active:2
Completed:21
Trial Phases
3 Phases
Phase 1:4
Phase 2:4
Not Applicable:23
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
23 (74.2%)Phase 1
4 (12.9%)Phase 2
4 (12.9%)Treatment for /s/ Production Errors in Children With Speech Sound Errors
Not Applicable
Recruiting
- Conditions
- Speech Sound Disorder
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Syracuse University
- Target Recruit Count
- 24
- Registration Number
- NCT07214480
- Locations
- 🇺🇸
Syracuse University, Syracuse, New York, United States
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Not Applicable
Recruiting
- Conditions
- Aphasia Following Cerebral InfarctionStroke IschemicFatigue Symptom
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- Syracuse University
- Target Recruit Count
- 60
- Registration Number
- NCT07151677
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Syracuse University, Syracuse, New York, United States
Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
Not Applicable
Recruiting
- Conditions
- Speech Sound Disorder
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Syracuse University
- Target Recruit Count
- 120
- Registration Number
- NCT07061730
- Locations
- 🇺🇸
Syracuse University, Syracuse, New York, United States
A Digital Resilience Intervention for Emergency Medical Service Workers
Not Applicable
Completed
- Conditions
- FeasibilityAcceptabilityAdoptabilityMeaning MadeAdaptive Self-reflectionRecovery ActivitiesRecovery ExperiencesPost Traumatic Stress Disorder PTSDAnxietyDepression
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Syracuse University
- Target Recruit Count
- 83
- Registration Number
- NCT06861400
- Locations
- 🇺🇸
Syracuse University, Syracuse, New York, United States
Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance
Not Applicable
Completed
- Conditions
- Vaccine Uptake
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Syracuse University
- Target Recruit Count
- 40
- Registration Number
- NCT06698497
- Locations
- 🇺🇸
Syracuse University, Syracuse, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
Novel Peptide Compounds Show Promise as Ozempic Alternatives with Reduced GI Side Effects
Researchers have developed two new peptide compounds, GEP44 and KCEM1, that target weight loss with potentially fewer gastrointestinal side effects than current GLP-1 drugs.